ARYD — ARYA Sciences Acquisition IV Balance Sheet
0.000.00%
Last trade - 00:00
- $85.24m
- $87.39m
- 28
- 34
- 41
- 26
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | — | 0.501 | 0.091 | 0.02 |
Prepaid Expenses | ||||
Total Current Assets | 0.002 | 0.87 | 0.146 | 0.077 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 0.042 | 150 | 152 | 40.7 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.056 | 5.99 | 6.27 | 12.4 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.056 | 11.2 | 8.89 | 15 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -0.014 | 139 | 143 | 25.7 |
Total Liabilities & Shareholders' Equity | 0.042 | 150 | 152 | 40.7 |
Total Common Shares Outstanding |